Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Outcome of Preferential Issue Committee Committee

 Glenmark Pharmaceuticals Ltd has informed BSE that the Preferential Issue Committee of the Board of Directors of the Company, at its Meeting held on May 19, 2015 allotted 1,08,00,000 Equity Shares of the face value of Re. 1/- each at a price of Rs. 875 per equity share to Aranda Investments (Mauritius) Pte Ltd., on preferential basis in terms of Chapter VII of SEBI (ICDR) Regulations and the applicable sections of the Companies Act, 2013.
19-05-2015
Bigul

FY15 results on May 29, 2015

 Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2015:1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2015.2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2015....
15-05-2015
Bigul

Glenmark Pharma gains on 'buy' rating

 Glenmark Pharmaceuticals has gained 2.4 per cent. CLSA has given it a "buy" rating and a target price of Rs 1,060. It says the drugmaker is at the cusp of a revival wi...
14-05-2015
Bigul

Disclosure of Voting results of EGM (Clause 35A)

 Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results at the Extra Ordinary General Meeting (EGM) of the Company held on May 13, 2015, under Clause 35A.
14-05-2015
Bigul

Addendum to Notice of EGM on May 13, 2015

 Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Addendum to Notice dated April 17, 2015 of Extraordinary General Meeting scheduled to be held on May 13, 2015.
06-05-2015
Bigul

Glenmark gets tentative USFDA nod for generic psoriasis cream

 Glenmark Pharmaceuticals has received tentative approval from the US health regulator for generic Calcipotriene cream, used for the treatment of plaque psoriasis. It said in a statement that Glenmark Pharmaceuticals Inc, USA, a subsidiary of ...
04-05-2015
Bigul

Glenmark rises on rating upgrade

 Glenmark Pharmaceuticals shares gained over 1 per cent on Monday after Bank of America Merrill Lynchs upgrade.The investment bank upgraded the stock to "buy" from "underperform".At 9...
04-05-2015
Bigul

Glenmark gets tentative USFDA nod for generic psoriasis cream

 Glenmark Pharmaceuticals has received tentative approval from the US health regulator for generic Calcipotriene cream, used for the treatment of plaque psoriasis. It said in a statement t...
04-05-2015
Bigul

Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene Cream, 0.005%

 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated May 04, 2015, titled "Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene Cream, 0.005%".
04-05-2015
Bigul

Glenmark Pharma gains on preferential issue plan to Temasek

 The stock up 4% at Rs 898 on the National Stock Exchange.
20-04-2015
Next Page
Close

Let's Open Free Demat Account